fashion -WSS

fashion

author：explore 2025-09-11 06:21:32 - browse：3259

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Merck CEO won’t testify in Senate, citing no expertise in drug prices

focus

WSS

Syphilis numbers in the United States reach record heights

ActiGraph execs on goal of drug approvals with digital endpoints

Medicare drug price negotiation legal challenge met with skepticism

Congress must give Medicare recipients genetic counseling access

Biogen walks away from Aduhelm, years after polarizing approval

FDA approves first treatment for ultra

leisure time

fashion

leisure time

Drug repurposing or repositioning? The language matters

Congress must give Medicare recipients genetic counseling access

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Duchenne breakthrough therapy leaves behind pioneering families

New definition of a human embryo proposed amid rapid advances

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New clues to why women have higher risk of autoimmune disorders

Medicare details structure of new drug price negotiation program

Clinical trials must include more disabled people

hotspot

Medicare Advantage insurers face 0.2% cut to 2025 payments

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

ActiGraph execs on goal of drug approvals with digital endpoints

Merck, Johnson & Johnson CEOs will testify on high drug prices

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

FDA approves first treatment for ultra

Wikipedia

focus

Wikipedia

entertainment